Search

everythinglearnresearchcommunity

for

Search:↓

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

PCOS treatment focuses on lifestyle changes and specific medications to manage symptoms and complications.

Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

Clascoterone may be a promising treatment for hair loss.

Spironolactone plus finasteride reduces hirsutism more effectively.

Certain extracts from Curcuma aeruginosa Roxb. and germacrone can boost the skin's absorption of minoxidil, a hair growth promoter, making it more effective.

Human skin cells contain Protease Nexin-1, and male hormones can decrease its levels, potentially affecting hair growth.

Targeting androgen receptor signaling may improve acute myeloid leukemia treatment.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Flutamide improves female hair loss when other treatments fail, but may cause liver toxicity.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Exercise improves insulin sensitivity and hormone regulation in PCOS rats.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Spironolactone is an effective and well-tolerated first-line treatment for hidradenitis suppurativa in women.

Steroids, particularly estrogens and 5α-reductase inhibitors, affect blood vessel-related hair growth processes in hair follicle cells.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.